Continuous cardiac rhythm monitoring via cardiac implantable electronic devices finds an increased number of patients with asymptomatic atrial fibrillation. Yet, not all patients with device-detected atrial high-rate episodes are alike. Fine-tuning risk assessment may help identify those who can benefit most from anticoagulation.
References
US Preventive Services Task Force. JAMA 327, 360–367 (2022).
Freedman, B. et al. Circulation 135, 1851–1867 (2017).
Healey, J. S. et al. N. Engl. J. Med. 366, 120–129 (2012).
Kirchhof, P. et al. N. Engl. J. Med. 389, 1167–1179 (2023).
Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A. & Crijns, H. J. Chest 137, 263–272 (2010).
Svendsen, J. H. et al. Lancet 398, 1507–1516 (2021).
Van Gelder, I. C. et al. Eur. Heart J. 38, 1339–1344 (2017).
Friberg, L., Rosenqvist, M. & Lip, G. Y. Eur. Heart J. 33, 1500–1510 (2012).
Diederichsen, S. Z. et al. JAMA Neurol. 79, 997–1004 (2022).
Svennberg, E. et al. Lancet 398, 1498–1506 (2021).
Shivkumar, K., Jafri, S. M. & Gheorghiade, M. Prog. Cardiovasc. Dis. 38, 337–342 (1996).
Chesebro, J. H., Fuster, V. & Halperin, J. L. N. Engl. J. Med. 323, 1556–1558 (1990).
Acknowledgements
P.H. was supported by American Heart Association Career Development Award 23CDA1039446. K.S. was supported by US National Institutes of Health grants P01HL164311 and R01HL162921.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
UCLA holds patents developed by K.S. relating to cardiac neural diagnostics and therapeutics. K.S. is a consultant for Nference Inc. & Anumana Inc.
Rights and permissions
About this article
Cite this article
Hanna, P., Buch, E. & Shivkumar, K. Are device-detected atrial high-rate episodes a risk marker for stroke?. Nat Cardiovasc Res 2, 1097–1098 (2023). https://doi.org/10.1038/s44161-023-00383-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s44161-023-00383-y
- Springer Nature Limited